Skip to main content

Table 1 Characteristics of patients with Behçet’s disease in the RISE registry

From: Epidemiology and treatment of Behçet’s disease in the USA: insights from the Rheumatology Informatics System for Effectiveness (RISE) Registry with a comparison with other published cohorts from endemic regions

Characteristics Total patients (N = 1323)
Age, mean (SD) 48.7 (16.3)
Sex (female), N (%) 1049 (79.3)
Race, N (%) White 882 (66.7)
Hispanic or Latino 72 (5.4)
Black or African American 65 (4.9)
Asian 34 (2.6)
Othera 106 (11.9)
Missing 164 (12.4)
Insurance, N (%) Medicare 205 (15.5)
Private 557 (42.1)
Medicaid 43 (3.2)
Otherb 75 (5.7)
Missing 443 (33.5)
U.S. geographic division, N (%) East North Central 22 (1.7)
West North Central 153 (11.6)
Mid-Atlantic 159 (12.0)
Mountain 109 (8.2)
New England 396 (29.9)
Pacific 116 (8.8)
South Atlantic 153 (11.6)
East South Central 62 (4.7)
West South Central 144 (10.9)
Missing < 10
Comorbidities, N (%) Osteoporosis 155 (11.7)
Hypertension 117 (8.8)
Hyperlipidemia 62 (4.7)
Cerebrovascular accidents /TIA 51 (3.7)
Diabetes mellitus 48 (3.6)
Charlson comorbidity index score, mean (SD) 0.55 (1.0)
Charlson comorbidity index score
 1 339 (25.6)
 ≥ 2 123 (9.3)
Clinical characteristics Number of visits in RISE, median (IQR) 4.5 (2.5, 8)
Duration of follow-up time (years), median (IQR) 2.5 (0.9, 4.4)
  1. RISE Rheumatology Informatics System for Effectiveness, TIA transient ischemic attack, IQR interquartile range
  2. aOther race: Not determined OMB race, and American Indian or Alaska, Native Hawaiian
  3. bOther insurance: include Veteran